--2025/Q1-- / 14.335B--
--2024/Q4-- / 17.284B--
Oct 29, 20242024/Q317.702B / 14.865B--
Jul 30, 20242024/Q213.283B / 13.019B--
May 1, 20242024/Q114.879B / 13.923B--
Overview | Pfizer exceeds Q3 expectations, further raises FY2024 outlook
Currency:USDOct 29, 2024
Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
Revenue | 14.87B | 17.70B | +2.84B |
Beat Est. | +12.34% | +31.21% | +19.08% |
EPS | 0.30 | 0.78 | +0.48 |
Beat Est. | +171.23% | +285.71% | +160.78% |
Nov 30, 2024
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Unlock Free Earnings Estimates
Read more
No Data
No Data